Sigma Planning Corp Increases Position in UnitedHealth Group Inc (UNH)

Sigma Planning Corp grew its stake in UnitedHealth Group Inc (NYSE:UNH) by 2.6% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,506 shares of the healthcare conglomerate’s stock after purchasing an additional 438 shares during the period. Sigma Planning Corp’s holdings in UnitedHealth Group were worth $3,429,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of UNH. Xact Kapitalforvaltning AB lifted its stake in shares of UnitedHealth Group by 7.8% in the 2nd quarter. Xact Kapitalforvaltning AB now owns 175,331 shares of the healthcare conglomerate’s stock valued at $32,510,000 after purchasing an additional 12,620 shares during the last quarter. Centre Asset Management LLC lifted its stake in shares of UnitedHealth Group by 12.0% in the 2nd quarter. Centre Asset Management LLC now owns 74,820 shares of the healthcare conglomerate’s stock valued at $13,873,000 after purchasing an additional 8,010 shares during the last quarter. Factory Mutual Insurance Co. raised its holdings in shares of UnitedHealth Group by 20.9% in the second quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock worth $77,245,000 after buying an additional 72,000 shares during the period. BKD Wealth Advisors LLC raised its holdings in shares of UnitedHealth Group by 4.2% in the second quarter. BKD Wealth Advisors LLC now owns 5,602 shares of the healthcare conglomerate’s stock worth $1,039,000 after buying an additional 228 shares during the period. Finally, Highwater Wealth Management LLC purchased a new stake in shares of UnitedHealth Group in the second quarter worth approximately $235,000. 86.01% of the stock is owned by institutional investors and hedge funds.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 457 shares of the firm’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Thomas E. Roos sold 975 shares of UnitedHealth Group stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the transaction, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The disclosure for this sale can be found here. Insiders have sold a total of 34,630 shares of company stock worth $7,669,416 over the last 90 days. 0.89% of the stock is currently owned by company insiders.

UNH has been the topic of several recent analyst reports. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price target on the stock in a report on Thursday, September 21st. Citigroup increased their price target on UnitedHealth Group from $213.00 to $235.00 and gave the stock a “buy” rating in a report on Wednesday, October 18th. Leerink Swann reiterated a “buy” rating and issued a $240.00 price target (up from $225.00) on shares of UnitedHealth Group in a report on Wednesday, October 18th. Cantor Fitzgerald reiterated a “buy” rating and issued a $208.00 price target on shares of UnitedHealth Group in a report on Tuesday, October 17th. Finally, Jefferies Group increased their price target on UnitedHealth Group from $215.00 to $225.00 and gave the stock a “buy” rating in a report on Friday, October 13th. Three equities research analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $229.54.

UnitedHealth Group Inc (UNH) opened at $228.64 on Friday. The company has a market capitalization of $221,060.00, a price-to-earnings ratio of 25.98, a price-to-earnings-growth ratio of 1.53 and a beta of 0.66. UnitedHealth Group Inc has a fifty-two week low of $156.09 and a fifty-two week high of $231.77. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. UnitedHealth Group’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the business posted $2.17 EPS. equities analysts predict that UnitedHealth Group Inc will post 9.99 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Markets Daily and is owned by of Markets Daily. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at https://www.themarketsdaily.com/2018/01/14/sigma-planning-corp-increases-position-in-unitedhealth-group-inc-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply